BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

616 related articles for article (PubMed ID: 27004407)

  • 21. C-Myc-dependent repression of two oncogenic miRNA clusters contributes to triptolide-induced cell death in hepatocellular carcinoma cells.
    Li SG; Shi QW; Yuan LY; Qin LP; Wang Y; Miao YQ; Chen Z; Ling CQ; Qin WX
    J Exp Clin Cancer Res; 2018 Mar; 37(1):51. PubMed ID: 29523159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Triptolide augments the effects of 5-lipoxygenase RNA interference in suppressing pancreatic tumor growth in a xenograft mouse model.
    Ding X; Zhou X; Zhang H; Qing J; Qiang H; Zhou G
    Cancer Chemother Pharmacol; 2012 Jan; 69(1):253-61. PubMed ID: 21713446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergistic anticancer effects of triptolide and celastrol, two main compounds from thunder god vine.
    Jiang QW; Cheng KJ; Mei XL; Qiu JG; Zhang WJ; Xue YQ; Qin WM; Yang Y; Zheng DW; Chen Y; Wei MN; Zhang X; Lv M; Chen MW; Wei X; Shi Z
    Oncotarget; 2015 Oct; 6(32):32790-804. PubMed ID: 26447544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Triptolide prevents bone loss via suppressing osteoclastogenesis through inhibiting PI3K-AKT-NFATc1 pathway.
    Cui J; Li X; Wang S; Su Y; Chen X; Cao L; Zhi X; Qiu Z; Wang Y; Jiang H; Huang B; Ji F; Su J
    J Cell Mol Med; 2020 Jun; 24(11):6149-6161. PubMed ID: 32347017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Triptolide inhibits tumor growth by induction of cellular senescence.
    Li R; Zhang X; Tian X; Shen C; Zhang Q; Zhang Y; Wang Z; Wang F; Tao Y
    Oncol Rep; 2017 Jan; 37(1):442-448. PubMed ID: 27878302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Triptolide inhibits colon-rectal cancer cells proliferation by induction of G1 phase arrest through upregulation of p21.
    Liu J; Shen M; Yue Z; Yang Z; Wang M; Li C; Xin C; Wang Y; Mei Q; Wang Z
    Phytomedicine; 2012 Jun; 19(8-9):756-62. PubMed ID: 22464014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human oncoprotein MDM2 activates the Akt signaling pathway through an interaction with the repressor element-1 silencing transcription factor conferring a survival advantage to cancer cells.
    Singh S; Ramamoorthy M; Vaughan C; Yeudall WA; Deb S; Palit Deb S
    Cell Death Differ; 2013 Apr; 20(4):558-66. PubMed ID: 23238568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells.
    Jiang XH; Wong BC; Lin MC; Zhu GH; Kung HF; Jiang SH; Yang D; Lam SK
    Oncogene; 2001 Nov; 20(55):8009-18. PubMed ID: 11753684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a new class of natural product MDM2 inhibitor: In vitro and in vivo anti-breast cancer activities and target validation.
    Qin JJ; Wang W; Voruganti S; Wang H; Zhang WD; Zhang R
    Oncotarget; 2015 Feb; 6(5):2623-40. PubMed ID: 25739118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergism of cytotoxicity effects of triptolide and artesunate combination treatment in pancreatic cancer cell lines.
    Liu Y; Cui YF
    Asian Pac J Cancer Prev; 2013; 14(9):5243-8. PubMed ID: 24175808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Triptolide Suppresses Growth of Breast Cancer by Targeting HMGB1 in Vitro and in Vivo.
    Jiang W; Chen M; Xiao C; Yang W; Qin Q; Tan Q; Liang Z; Liao X; Mao A; Wei C
    Biol Pharm Bull; 2019 Jun; 42(6):892-899. PubMed ID: 30956264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer-specific enhancement of cisplatin-induced cytotoxicity with triptolide through an interaction of inactivated glycogen synthase kinase-3beta with p53.
    Matsui Y; Watanabe J; Ikegawa M; Kamoto T; Ogawa O; Nishiyama H
    Oncogene; 2008 Jul; 27(33):4603-14. PubMed ID: 18391982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spiro-oxindole derivative 5-chloro-4',5'-diphenyl-3'-(4-(2-(piperidin-1-yl) ethoxy) benzoyl) spiro[indoline-3,2'-pyrrolidin]-2-one triggers apoptosis in breast cancer cells via restoration of p53 function.
    Saxena R; Gupta G; Manohar M; Debnath U; Popli P; Prabhakar YS; Konwar R; Kumar S; Kumar A; Dwivedi A
    Int J Biochem Cell Biol; 2016 Jan; 70():105-17. PubMed ID: 26556313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Triptolide inhibits Epstein-Barr nuclear antigen 1 expression by increasing sensitivity of mitochondria apoptosis of nasopharyngeal carcinoma cells.
    Zhou H; Liu Y; Wang C; Liu L; Wang H; Zhang Y; Long C; Sun X
    J Exp Clin Cancer Res; 2018 Aug; 37(1):192. PubMed ID: 30111354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platycodin D, a metabolite of Platycodin grandiflorum, inhibits highly metastatic MDA-MB-231 breast cancer growth in vitro and in vivo by targeting the MDM2 oncogene.
    Kong Y; Lu ZL; Wang JJ; Zhou R; Guo J; Liu J; Sun HL; Wang H; Song W; Yang J; Xu HX
    Oncol Rep; 2016 Sep; 36(3):1447-56. PubMed ID: 27432230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activity of triptolide against human mast cells harboring the kinase domain mutant KIT.
    Jin Y; Chen Q; Shi X; Lu Z; Cheng C; Lai Y; Zheng Q; Pan J
    Cancer Sci; 2009 Jul; 100(7):1335-43. PubMed ID: 19383029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 2-Methoxy-5((3,4,5-trimethosyphenyl)seleninyl) phenol inhibits MDM2 and induces apoptosis in breast cancer cells through a p53-independent pathway.
    Xu J; Han M; Shen J; Guan Q; Bai Z; Lang B; Zhang H; Li Z; Zuo D; Zhang W; Wu Y
    Cancer Lett; 2016 Dec; 383(1):9-17. PubMed ID: 27693458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic antitumour effects of triptolide plus 10-hydroxycamptothecin onbladder cancer.
    Wang T; Ding Y; Yang Y; Wang Z; Gao W; Li D; Wei J; Sun Y
    Biomed Pharmacother; 2019 Jul; 115():108899. PubMed ID: 31063955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Triptolide inhibits PDGF-induced proliferation of ASMCs through G0/G1 cell cycle arrest and suppression of the AKT/NF-κB/cyclinD1 signaling pathway.
    He S; Chen M; Lin X; Lv Z; Liang R; Huang L
    Eur J Pharmacol; 2020 Jan; 867():172811. PubMed ID: 31756335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Triptolide decreases expression of latency-associated nuclear antigen 1 and reduces viral titers in Kaposi's sarcoma-associated and herpesvirus-related primary effusion lymphoma cells.
    Long C; Guo W; Zhou H; Wang J; Wang H; Sun X
    Int J Oncol; 2016 Apr; 48(4):1519-30. PubMed ID: 26821279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.